|
| |
| | | 69710 | | 31.03.2025 | | Daiichi Sankyo (Schweiz) AG | | | | | | | 30.03.2030 | | | | | | | | | | 07.16.10. | | |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | VANFLYTA 17.7 mg | Filmtabletten | Filmtabletten (Quizartinibi Dihydrochloridum 20 mg) | L01EX11 | | | 02 | VANFLYTA 26.5 mg | Filmtabletten | Filmtabletten (Quizartinibi Dihydrochloridum 30 mg) | L01EX11 | |
|
|
|
